Goldman Sachs Group Inc. Raises Stock Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Goldman Sachs Group Inc. increased its stake in Mettler-Toledo International by 15.7% in the first quarter, owning 169,805 shares valued at approximately $200.5 million.
• Mettler-Toledo reported earnings of $10.09 EPS for the quarter, exceeding expectations, with a revenue of $983.22 million, reflecting a 3.9% year-over-year increase.
• Analysts have set a consensus price target of $1,311.11 for Mettler-Toledo, with various brokerages updating their ratings and price objectives recently.

Goldman Sachs Group Inc. grew its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 15.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 169,805 shares of the medical instruments supplier's stock after acquiring an additional 22,992 shares during the quarter. Goldman Sachs Group Inc. owned about 0.82% of Mettler-Toledo International worth $200,524,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in MTD. Captrust Financial Advisors lifted its position in shares of Mettler-Toledo International by 11.6% in the fourth quarter. Captrust Financial Advisors now owns 656 shares of the medical instruments supplier's stock valued at $802,000 after acquiring an additional 68 shares in the last quarter. Cetera Investment Advisers increased its stake in Mettler-Toledo International by 8.7% in the fourth quarter. Cetera Investment Advisers now owns 1,075 shares of the medical instruments supplier's stock valued at $1,315,000 after purchasing an additional 86 shares during the last quarter. D. E. Shaw & Co. Inc. increased its stake in Mettler-Toledo International by 212.0% in the fourth quarter. D. E. Shaw & Co. Inc. now owns 10,192 shares of the medical instruments supplier's stock valued at $12,472,000 after purchasing an additional 6,925 shares during the last quarter. Focus Partners Wealth increased its stake in Mettler-Toledo International by 8.5% in the fourth quarter. Focus Partners Wealth now owns 1,721 shares of the medical instruments supplier's stock valued at $2,106,000 after purchasing an additional 135 shares during the last quarter. Finally, Graham Capital Management L.P. acquired a new position in Mettler-Toledo International in the fourth quarter valued at $683,000. 95.07% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts recently commented on the company. Robert W. Baird upped their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Barclays assumed coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 target price for the company. Evercore ISI dropped their target price on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research note on Monday, August 4th. UBS Group upgraded Mettler-Toledo International from a "neutral" rating to a "buy" rating and dropped their target price for the company from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Citigroup upped their price target on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the stock a "buy" rating in a research note on Thursday, August 21st. Five investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company's stock. According to MarketBeat.com, Mettler-Toledo International has a consensus rating of "Moderate Buy" and a consensus price target of $1,311.11.

Insider Transactions at Mettler-Toledo International

In other news, CFO Shawn Vadala sold 300 shares of the company's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the completion of the sale, the chief financial officer owned 5,095 shares of the company's stock, valued at $6,750,875. This represents a 5.56% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Thomas P. Salice sold 1,062 shares of the company's stock in a transaction dated Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total value of $1,381,555.80. Following the completion of the sale, the director directly owned 283 shares of the company's stock, valued at $368,154.70. The trade was a 78.96% decrease in their position. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock valued at $2,371,208 over the last quarter. Company insiders own 0.77% of the company's stock.

Mettler-Toledo International Stock Up 1.3%

Shares of NYSE MTD traded up $16.66 on Tuesday, hitting $1,276.79. The company had a trading volume of 124,222 shares, compared to its average volume of 117,195. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01. The business has a 50 day moving average of $1,261.83 and a two-hundred day moving average of $1,185.40. The firm has a market capitalization of $26.30 billion, a P/E ratio of 32.33, a PEG ratio of 3.78 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The company had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. During the same quarter in the prior year, the business earned $9.65 earnings per share. The company's revenue was up 3.9% compared to the same quarter last year. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. On average, sell-side analysts anticipate that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.